Meridian Bioscience Inc. (VIVO): Price and Financial Metrics

Meridian Bioscience Inc. (VIVO): $33.97

0.00 (0.00%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

A

VIVO Price/Volume Stats

Current price $33.97 52-week high $34.38
Prev. close $33.97 52-week low $20.35
Day low $33.93 Volume 6,422,800
Day high $34.02 Avg. volume 973,737
50-day MA $32.89 Dividend yield N/A
200-day MA $31.01 Market Cap 1.49B

VIVO Stock Price Chart Interactive Chart >


Meridian Bioscience Inc. (VIVO) Company Bio


Meridian Biosciences is a fully integrated life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and related products and offers biopharmaceutical enabling technologies. The company was founded in 1976 and is based in Cincinnati, Ohio.


VIVO Latest News Stream


Event/Time News Detail
Loading, please wait...

VIVO Latest Social Stream


Loading social stream, please wait...

View Full VIVO Social Stream

Latest VIVO News From Around the Web

Below are the latest news stories about MERIDIAN BIOSCIENCE INC that investors may wish to consider to help them evaluate VIVO as an investment opportunity.

Meridian Biosciences Stock: Why I Moved On But May Go Back In (NASDAQ:VIVO)

Meridian Biosciences released an update saying it set the closing date for its merger on Jan. 31. Read more on this deal and implications for investors.

Seeking Alpha | December 13, 2022

Meridian Bioscience stock gains after announcing Jan. 31 closing date for sale

Meridian Bioscience (VIVO) rose 8% after it said its planned sale to SD Biosensor, SJL Partners is expected to close on Jan

Seeking Alpha | December 12, 2022

Meridian Bioscience sets closing date for $1.53 billion deal

On Monday, officials with Meridian Bioscience Inc., a provider of diagnostic testing and life science raw materials, announced their pending $1.53 billion merger with two South Korean-based firms will close Jan. 31.

Yahoo | December 12, 2022

Meridian Bioscience Announces Anticipated Closing Date of the Pending Merger

Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced that it has entered into a side letter with the buyer, setting the closing date of Meridian's pending merger for January 31, 2023.

Yahoo | December 12, 2022

Meridian Bioscience Fiscal Q4 Revenues Fall 14 Percent, Full-Year Revenues Grow 5 Percent

The firm''s diagnostics segment revenues climbed 14 percent year over year in fiscal Q4, while life sciences revenues were down 37 percent.

GenomeWeb | November 22, 2022

Read More 'VIVO' Stories Here

VIVO Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year 68.67%
5-year 195.13%
YTD N/A
2023 0.00%
2022 62.79%
2021 9.15%
2020 91.30%
2019 -43.29%

Continue Researching VIVO

Want to see what other sources are saying about Meridian Bioscience Inc's financials and stock price? Try the links below:

Meridian Bioscience Inc (VIVO) Stock Price | Nasdaq
Meridian Bioscience Inc (VIVO) Stock Quote, History and News - Yahoo Finance
Meridian Bioscience Inc (VIVO) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!